Cite
Robertson SM, Scarsi KK, Postelnick MJ, et al. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review. Pharmacotherapy. 2005;25(8):1068-72doi: 10.1592/phco.2005.25.8.1068.
Robertson, S. M., Scarsi, K. K., Postelnick, M. J., & Lynch, P. (2005). Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review. Pharmacotherapy, 25(8), 1068-72. https://doi.org/10.1592/phco.2005.25.8.1068
Robertson, Sarah M, et al. "Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review." Pharmacotherapy vol. 25,8 (2005): 1068-72. doi: https://doi.org/10.1592/phco.2005.25.8.1068
Robertson SM, Scarsi KK, Postelnick MJ, Lynch P. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review. Pharmacotherapy. 2005 Aug;25(8):1068-72. doi: 10.1592/phco.2005.25.8.1068. PMID: 16207097.
Copy
Download .nbib